Overall, our findings are in line with a role of osteopontin in acute MS relapses and suggest that, near relapses, the CSF expression of osteopontin is increased and associated with higher levels of IL-2 and IL-6 and reduced IL-1ra concentrations. Here, IL2 is linked to myeloid sarcoma.